相关实验视频
Updated: Jun 14, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.8K
在先天性心脏病与先天性腹膜的手术方法:多机构分析
Kylie I Holden1, Ashley H Ebanks1, Amir M Khan1
1McGovern Medical School at the University of Texas Health Science Center, Houston, TX.
The Annals of thoracic surgery
|August 23, 2025
概括
在患有先天性心脏病和腹膜的婴儿心脏手术的最佳时间是至关重要的. 在先天性隔膜修复后30至80天进行心脏修复可以改善存活率.
科学领域:
- 儿童手术
- 遗传异常
- 心脏病学
背景情况:
- 遗传性心脏病 (CHD) 和遗传性隔膜 (CDH) 经常一起发生,这给手术带来了重大挑战.
- 这两种情况的最佳手术时间尚未明确.
研究的目的:
- 分析手术时间和患者结局之间的关系.
- 为CDH+CHD患者提供基于证据的手术决策指导.
主要方法:
- 来自多机构注册表的1886名CDH+CHD患者的回顾性分析 (2007-2022年).
- 分析了CDH缺陷的大小和心脏异常 (按STAT类别分层).
- 多变量回归和洛斯平滑模型评估死亡率作为缺陷大小和手术时间的函数.
主要成果:
- 总体死亡率为23. 4%. 身体外生命支持是住院死亡的重要预测因素.
- 在STAT类别中,患者死亡率与CDH严重程度相关 (CDHSG阶段).
- 隔膜修复和心脏手术之间的中位时间为46天;当心脏手术发生在CDH修复后30至80天时,存活率最高.
结论:
- 在CDH+CHD患者的手术结果受CDH严重程度和心脏风险的影响 (STAT类别).
- 隔膜修复通常在心脏修复之前进行.
- 心脏手术的最佳时间是CDH修复后30-80天,以指导目前的手术实践.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

